Literature DB >> 18163416

Missing data in trials: do we have to keep carrying the last observation forward?

Maarten Boers.   

Abstract

Mesh：

Year:  2008        PMID： 18163416     DOI： 10.1002/art.23254

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  2 in total

1.  Efficacy and Safety of Opinercept Tumor Necrosis Factor Inhibitor Therapy for Drug-Refractory Rheumatoid Arthritis: A Randomized Clinical Trial.

Authors:  Toong-Hua Liang; Chyou-Shen Lee; Shinn-Shing Lee; Chien-Sheng Wu; Kun-Hung Chen; Ping-Ning Hsu; Hsiao-Yi Lin
Journal:  Arch Rheumatol       Date:  2020-01-08       Impact factor: 1.472

2.  Interpreting trial results following use of different intention-to-treat approaches for preventing attrition bias: a meta-epidemiological study protocol.

Authors:  Anna Dossing; Simon Tarp; Daniel E Furst; Christian Gluud; Joseph Beyene; Bjarke B Hansen; Henning Bliddal; Robin Christensen
Journal:  BMJ Open       Date:  2014-09-26       Impact factor: 2.692
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.